Dachaigh › Leukemia Myeloid Cronach
Sgrùdaidhean clionaigeach Leukemia Myeloid Cronach a’ fastadh anns na SA
Tha 48 sgrùdaidhean airson Leukemia Myeloid Cronach a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX18 sgrùdaidhean
- New York City, NY11 sgrùdadh
- Seattle, WA11 sgrùdadh
- Philadelphia, PA6 sgrùdaidhean
- Portland, OR6 sgrùdaidhean
- Birmingham, AL6 sgrùdaidhean
- Detroit, MI6 sgrùdaidhean
- Baldwin Park, CA6 sgrùdaidhean
- Chicago, IL6 sgrùdaidhean
- Durham, NC5 sgrùdaidhean
- Nashville, TN5 sgrùdaidhean
- Boston, MA5 sgrùdaidhean
- Baltimore, MD5 sgrùdaidhean
- Milwaukee, WI5 sgrùdaidhean
- Atlanta, GA5 sgrùdaidhean
- Columbus, OH5 sgrùdaidhean
- Mountain View, CA4 sgrùdaidhean
- Augusta, GA4 sgrùdaidhean
- Kansas City, MO4 sgrùdaidhean
- St. Louis, MO4 sgrùdaidhean
- Rochester, NY4 sgrùdaidhean
- Washington, DC4 sgrùdaidhean
- Cincinnati, OH4 sgrùdaidhean
- Miami, FL3 sgrùdaidhean
- Orange, CA3 sgrùdaidhean
- Greenville, NC3 sgrùdaidhean
- St. Petersburg, FL3 sgrùdaidhean
- Salt Lake City, UT3 sgrùdaidhean
- Buffalo, NY3 sgrùdaidhean
- Minneapolis, MN3 sgrùdaidhean
- Edison, NJ3 sgrùdaidhean
- Aurora, CO3 sgrùdaidhean
- Ann Arbor, MI3 sgrùdaidhean
- Cleveland, OH3 sgrùdaidhean
- Sacramento, CA3 sgrùdaidhean
- Bridgeport, CT3 sgrùdaidhean
Le stàit
- Alabama6 sgrùdaidhean
- Arizona4 sgrùdaidhean
- California10 sgrùdaidhean
- Colorado4 sgrùdaidhean
- Florida7 sgrùdaidhean
- Georgia7 sgrùdaidhean
- Illinois6 sgrùdaidhean
- Indiana3 sgrùdaidhean
- Kansas5 sgrùdaidhean
- Kentucky3 sgrùdaidhean
- Maryland6 sgrùdaidhean
- Massachusetts5 sgrùdaidhean
- Michigan7 sgrùdaidhean
- Minnesota4 sgrùdaidhean
- Missouri4 sgrùdaidhean
- Nebraska3 sgrùdaidhean
- New Jersey4 sgrùdaidhean
- New York15 sgrùdaidhean
- North Carolina8 sgrùdaidhean
- Ohio9 sgrùdaidhean
- Oregon6 sgrùdaidhean
- Pennsylvania7 sgrùdaidhean
- Sgìre Cholumbia3 sgrùdaidhean
- Tennessee5 sgrùdaidhean
- Texas18 sgrùdaidhean
- Utah3 sgrùdaidhean
- Virginia4 sgrùdaidhean
- Washington11 sgrùdadh
- Wisconsin5 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
A’ fastadhÌre 1 tràth
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06398457Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06904066Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06817720Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
A’ fastadhSgrùdadh amharc
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06236724Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07269470Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
A’ fastadhÌre 1/2
Aoisean 1 gu 17 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04925479Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
A’ fastadhÌre 1
Aoisean 1 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT03630991Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06423911Cord Blood Transplant in Adults With Blood Cancers
A’ fastadhÌre 2
Aoisean 21 gu 65 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT05884333Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
A’ fastadhÌre 2
Aoisean 1 gu 18 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07354074Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT06523556Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
A’ fastadhÌre 1
1 Day – 21 Years · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT05857969Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04838041TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
A’ fastadhÌre 1
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT07302776Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
A’ fastadhÌre 2
6 Months – 65 Years · Gach gnè · Air ùrachadh 22 Iuch 2026 · NCT06013423A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545Allo HSCT Using RIC and PTCy for Hematological Diseases
A’ fastadhÌre 2
Suas gu aois 75 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT05805605Asciminib Roll-over Study
A’ fastadhÌre 4
Aoisean 7 gu 100 · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT04877522Registry of Older Patients With Cancer
A’ fastadhSgrùdadh amharc
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT01137825Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
A’ fastadhÌre 2
Suas gu aois 60 · Gach gnè · Air ùrachadh 25 Ògmh 2026 · NCT03314974Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT05549661Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT07638007Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.